Global Head of Business Development
Dr. De Lecea joined Emisphere as Global Head of Business Development in February of 2013. His career spans over 25 years at every level of the biopharmaceutical industry.
Most recently, he was Vice President of International & Business development at Grupo Ferrer International, where he and his team presided over a successful venture that was focused on the acquisition, marketing, and commercialization of proprietary and in-licensed products. A major portion of Dr. De Lecea's highly successful career includes the transformation of an essentially domestic business of the Group into a broad international operation, including the creation from scratch of over a dozen new affiliates; and established a new network of joint-ventures, licensing and distribution agreements across 93 countries in the world. During his tenure at Ferrer, Dr. de Lecea set up Ferrer's international commercial infrastructure, all sales and marketing activities for Ferrer's product portfolio and oversaw management of all worldwide business development initiatives. Dr. De Lecea led many key top level executive initiatives and presided over numerous commercial product launches across a spectrum of therapeutic areas including orphan drugs; hospital products; Rx products in the CNS, cardiovascular, gastro and derma fields; OTCs; medical devices and diagnostics.
Dr. De Lecea currently serves as a member of the Board of Directors of Aurum Biosciences, CEO of Lemus Buhils SL, and as Advisor to the Board at Kinesis Consulting, Recerca Clinica and AB Biotics. Dr. De Lecea is Certified by IESE Business School in the Management of Health Care Institutions. He also followed IESE’s PADE one of the most prestigious executive education management courses in the world. Dr. de Lecea is MD and Specialist in Anesthesiology and Critical Care from the University of Barcelona, Spain and is licensed to practice. He was also trained in Endocrinology in the EU.